Analystreport

iRadimed (NASDAQ:IRMD) had its "buy" rating reaffirmed by analysts at Lake Street Capital.

iRadimed Corporation  (IRMD) 
Last iradimed corporation earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: iradimed.com/en-us/investors/investor-contact